Stay updated on ABP 980 vs Trastuzumab in HER2+ Early Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the ABP 980 vs Trastuzumab in HER2+ Early Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABP 980 vs Trastuzumab in HER2+ Early Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Updated the study locations: new sites across multiple countries have been added and several existing locations removed. This changes where participants can enroll and where the study is conducted.
    Difference
    3%
    Check dated 2025-12-23T22:56:28.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The Publications section now notes that publications are automatically filled from PubMed and displays Revision: v3.3.2. The previous wording indicating PubMed publications were provided directly (Revision: v3.2.0) was removed.
    Difference
    0.1%
    Check dated 2025-11-25T13:39:09.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The government funding/operating status notice has been removed from the page. This change does not affect the core study details, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T07:20:04.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The new screenshot shows minor layout adjustments to the Study Details page, with slight rearrangement of sections and updated visuals, but the core study information remains the same.
    Difference
    0.2%
    Check dated 2025-11-03T21:22:49.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Updated operating-status notice and version 3.2.0; removed version 3.1.0.
    Difference
    3%
    Check dated 2025-10-06T06:59:35.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:44:01.000Z thumbnail image

Stay in the know with updates to ABP 980 vs Trastuzumab in HER2+ Early Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABP 980 vs Trastuzumab in HER2+ Early Breast Cancer Clinical Trial page.